Brief: Advance Nanotek Announces Reduced Covid-19 Impact On Sales
July 1 (Reuters) - Advance Nanotek Ltd ANO.AX :
* REDUCED COVID-19 IMPACT ON SALES
* COMBINED SALES ORDERS AND FUTURE SALES FORECASTS AT
PRESENT FROM
JULY TO DECEMBER 2021, TOTALLING ABOUT $10 MILLION
* IN PROCESS OF FINALISING BRISBANE FACILITY TO BE FULLY
CERTIFIED
AS VEGAN WITH VEGECERT AND CERTIFIED AS ORGANIC WITH ACO
* DETERMINED BECOMING DUAL LISTED WITH SHARES TO BE TRADED
ON BOTH
ASX AND NASDAQ, APPEARS TO BE BEST OPTION FOR SHAREHOLDERS
Source text for Eikon: ID:nASX8YNtP4
Further company coverage: ANO.AX
Recent news on Advance Zinctek
See all newsAustralia's Advance ZincTek hits 8-year low on weaker sunscreen orders
Brief: Advance Zinctek Expects To Report A Profit Before Tax Of A$2.294 Million For FY26
Brief: Advance Zinctek Confirms Capital Return Of A$0.02 Per Share
Brief: Advance Zinctek Responds To TV Broadcast On Allegations Concerning Zinc Oxide Supplied By ANO In 2024
Brief: Advance Zinctek Says FDA Identifies GMP Compliance Issues Requiring Remediation